Clustering data with hclust algorithm for Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples (Study ST000081)

ESI/QTOF positive ion mode (Analysis AN000131)
MetaboliteStructureF1F2F3
LPC (20:4)ME6559722.651.080.76
LPC (18:0)ME6559690.450.391.67
LPC (18:1)ME6559700.420.341.72
1-Octadecanoyl-sn-glycero-3-phosphoethanolamineME6559500.230.281.79
LPC (16:0)ME6559680.290.341.73
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)ME6559660.200.521.56
PC (38:6) AME6560000.330.671.40
TG (50:3)ME6560571.730.861.07
TG (52:5)ME6560681.650.871.06
TG (56:6)ME6560871.690.871.06
SM (d40:2) BME6560361.600.901.04
TG (52:4)ME6560671.560.881.06
LPC (18:2)ME6559711.560.851.10
TG (50:4)ME6560581.540.861.08
TG (50:5)ME6560591.540.871.08
plasmenyl-PC (36:3)ME6560181.171.150.84
PC (p-38:5) or PC (o-38:6)ME6560131.591.160.78
PC (p-36:4) or PC (o-36:5)ME6560111.471.130.82
SM (d18:1/16:1)ME6560311.491.070.88
1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholineME6559490.761.060.96
TG (48:0)ME6560460.610.931.11
TG (49:0)ME6560500.620.931.10
TG (50:0)ME6560540.680.951.08
TG (55:1)ME6560790.710.931.10
SM (33:1)ME6560250.791.001.02
TG (50:1)ME6560550.790.961.06
TG (51:0)ME6560600.640.991.05
PC (p-32:0) or PC (o-32:1)ME6560070.681.031.00
TG (53:1)ME6560700.710.971.06
TG (52:0)ME6560650.711.001.03
TG (54:1)ME6560740.730.991.04
PE (p-38:4) or PE (o-38:5)ME6560160.880.881.13
TG (46:1)ME6560430.900.861.15
SM (d41:1)ME6560370.760.911.12
TG (51:1)ME6560610.780.921.10
PC (30:1)ME6559770.820.861.16
PC (37:4)ME6559950.820.871.14
SM (d18:1/16:0)ME6560300.840.891.13
PC (34:4)ME6559870.810.891.12
TG (44:2)ME6560410.810.891.13
TG (58:9)ME6560990.920.781.23
TG (54:7) BME6560780.960.791.22
PC (36:2)ME6559910.940.801.21
SM (d16:1/20:0)ME6560270.920.801.20
TG (58:8)ME6560980.870.761.25
DG (38:5)ME6559650.890.781.23
PC (38:4) AME6559980.880.781.23
DG (34:1)ME6559600.860.801.21
PC (40:8)ME6560050.870.791.22
TG (60:2)ME6561000.900.821.19
PC (34:3)ME6559860.840.841.17
TG (62:2)ME6561030.840.831.19
PC (32:2)ME6559800.870.841.17
TG (58:2)ME6560930.870.821.19
TG (57:2)ME6560900.780.851.17
PC (40:6) AME6560030.790.811.21
PE (p-40:5) or PE (o-40:6)ME6560170.810.831.19
PC (34:1)ME6559840.820.811.20
PE (36:1)ME6560140.810.821.20
DG (36:3)ME6559630.680.631.40
DG (34:2)ME6559610.800.751.27
DG (36:2)ME6559620.790.691.33
DG (30:0)ME6559580.720.861.17
TG (44:1)ME6560400.740.861.17
TG (49:1)ME6560510.720.891.13
TG (56:1)ME6560830.700.881.15
DG (32:0)ME6559590.640.831.21
PC (33:2)ME6559820.650.821.21
PC (30:0)ME6559760.660.851.18
TG (58:1)ME6560920.650.851.18
plasmenyl-PE (34:1)ME6560190.690.851.18
PC (33:1)ME6559810.670.831.20
PC (35:2)ME6559890.690.831.20
plasmenyl-PE (38:3)ME6560220.630.871.17
TG (42:0)ME6560380.600.881.16
TG (46:0)ME6560420.670.901.13
plasmenyl-PE (34:2)ME6560200.660.881.16
TG (42:1)ME6560390.670.881.16
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholineME6559730.600.761.28
PC (36:3) AME6559920.620.791.25
PC (38:3)ME6559970.630.781.26
plasmenyl-PE (40:4)ME6560240.680.761.28
PC (38:2)ME6559960.680.781.25
PC (38:5) AME6559990.690.771.26
PC (40:4)ME6560010.730.771.26
PC (40:5) BME6560020.740.761.26
PC (35:1)ME6559880.740.811.21
PC (34:2)ME6559850.700.801.23
Acylcarnitine C16:0ME6559520.720.791.24
Oleoyl ethylamideME6559740.730.801.23
DG (38:4)ME6559640.730.791.23
PC (36:4)ME6559930.730.791.23
plasmenyl-PE (36:1)ME6560210.580.831.22
SM (34:0)ME6560260.580.831.21
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamineME6559510.530.841.21
PC (31:0)ME6559780.510.831.22
PC (36:5)ME6559940.520.821.23
PC (34:0)ME6559830.590.711.34
PC (40:6) BME6560040.510.731.32
CholineME6559570.530.741.30
PC (o-32:0)ME6560060.510.761.29
PC (16:0/16:0)ME6559750.510.751.30
PC (32:0)ME6559790.520.751.30
TG (50:2)ME6560561.470.901.05
TG (56:5)ME6560861.420.901.06
TG (48:3)ME6560491.440.861.10
TG (48:2)ME6560481.400.871.09
TG (56:3)ME6560851.420.861.09
SM (d16:1/20:1)ME6560281.380.881.08
TG (53:4)ME6560731.340.881.08
TG (58:7)ME6560971.200.761.22
TG (58:3)ME6560941.170.831.15
TG (60:4)ME6561021.200.821.16
TG (52:6)ME6560691.330.851.11
TG (54:6)ME6560771.320.841.13
TG (58:4) AME6560951.270.811.16
TG (58:6)ME6560961.290.801.17
TG (56:7)ME6560881.270.851.13
TG (60:3)ME6561011.240.831.15
TG (62:3)ME6561041.230.851.13
TG (54:5)ME6560761.210.891.09
TG (49:2)ME6560521.160.881.10
TG (55:3)ME6560811.180.881.10
TG (55:4)ME6560821.180.891.10
TG (53:3)ME6560721.290.881.09
TG (49:3)ME6560531.250.891.09
TG (51:3)ME6560631.250.901.08
TG (51:4)ME6560641.250.901.07
Ceramide (d40:1)ME6559541.110.731.26
Ceramide (d42:2)ME6559551.070.721.27
TG (48:1)ME6560471.020.911.08
TG (53:2)ME6560711.000.931.07
TG (56:2)ME6560840.990.891.11
SM (d40:1)ME6560350.980.871.13
TG (57:3)ME6560910.970.871.14
Acylcarnitine C18:1ME6559531.000.831.17
PC (36:1)ME6559901.020.791.21
SM (d38:1)ME6560341.070.821.17
TG (56:8)ME6560891.050.831.16
TG (46:3)ME6560451.100.861.13
SM (d18:2/24:1)ME6560331.060.871.12
TG (46:2)ME6560441.040.861.13
PC (p-38:4) A or PC (o-38:5) AME6560121.150.981.01
plasmenyl-PE (38:5)ME6560231.210.941.04
PE (p-36:4) or PE (o-36:5)ME6560151.040.951.05
CholesterolME6559561.060.981.02
PC (p-34:1) or PC (o-34:2) AME6560081.080.971.02
TG (51:2)ME6560621.130.901.08
SM (d18:2/23:0)ME6560321.100.921.07
TG (54:2)ME6560751.070.921.07
SM (d18:1/14:0)ME6560290.930.981.03
TG (52:1)ME6560660.870.961.05
TG (55:2)ME6560800.890.921.09
PC (p-34:2) or PC (o-34:3)ME6560101.021.080.92
HydromorphoneME6559670.921.050.96
PC (p-34:1) or PC (o-34:2) BME6560090.951.060.95

Factors:

F1Tissue type:Adipose Tissue_QC
F2Tissue type:Subcutaenous Adipose
F3Tissue type:Visceral Adipose
Data matrix
  logo